Otonomy, Inc.Otonomy, Inc.Otonomy, Inc.Otonomy, Inc., a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, reported financial results for the quarter ended June 30, 2021 and provided an update on its product pipeline and corporate activities.
August 4, 2021
· 14 min read